In addition, ATPsynb was also reported to function as an antiviral by interacting with VP292, an envelope protein of WSVV, implying an increase in the demand for energy during the process of fighting viral infection (Bourchookarn et al., 2008; Li et al., 2013). This evidence concerns the gene ERVW-1 and viral infectious disease.